GB2339903A - Fluid container - Google Patents
Fluid container Download PDFInfo
- Publication number
- GB2339903A GB2339903A GB9815941A GB9815941A GB2339903A GB 2339903 A GB2339903 A GB 2339903A GB 9815941 A GB9815941 A GB 9815941A GB 9815941 A GB9815941 A GB 9815941A GB 2339903 A GB2339903 A GB 2339903A
- Authority
- GB
- United Kingdom
- Prior art keywords
- blood
- fluid
- volume
- testing
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
- A61J1/12—Bag-type containers with means for holding samples of contents
Description
2339903 Blood Bae The present invention concerns sealable fluid
containers, particularly containers for biological fluids, and more particularly blood bags, the containers having multiple use diagnostic test means to test their contents whilst the container as a whole is sealed.
Testing of the contents of blood bags has previously been proposed - WO 92/19764 discloses a method and apparatus to detect bacterial contamination of transfusable blood, comprising attaching a flexible blood sample collecting bag to main blood bag by means of a tube through which a sample of blood is passed.
The sample bag contains a bacterial growth medium which allows microorganisms present in the blood sample to be grown within the sample bag, thereby providing an indication of the presence or absence of contaminating micro-organisms. The test can be carried out immediately prior to transfusion. However, the method of testing requires the growth of bacteria in culture and this takes a numbers of hours, so that an immediate result is not obtainable. Furthermore, the presence of the sample bag containing microbial growth medium in itself poses a risk of contamination in that it provides a bacterial growth medium which may in itself promote the growth of bacteria within the blood, particularly if there is any backflow from the sample bag into the main blood volume.
US 4,945,060 discloses a container having a sealable, sterilizable vessel for detecting the presence of microorganisms in a specimen, the vessel containing a liquid culture medium and a sensor means with an indicator medium therein. Changes in the indicator medium resulting from pH change or change in carbon dioxide concentration in the medium are detected from outside the vessel.
US 4,182,656 discloses testing for bacterial contamination of a sample by placing the sample in a sealable container containing a culture medium containing a carbon- 13 labelled ferTnentation substrate, the container and its contents being subjected to conditions conducive to biological activity and any "C02produced by fermentation detected indicating the presence of biologically active agents (i.e. bacteria) in the sample.
Thus it is known to test the contents of e.g. blood bags to determine their sterility or otherwise. However, they each require e.g. the use of radioactive isotopes or that the seal of the container be broken in order to remove a sample for testing, or provide an environment which potentially encourages a loss of sterility.
Typical hospital practise nowadays means that once a blood sample has been initially collected and cooled, it may be removed from refrigerated storage and allowed to warm on several occasions for possible use in surgical procedures prior to its actually being used. This repeated heating and cooling poses a significant thereat of bacterial growth occurring and means by the time that the blood is finally used it may be contaminated even though it was initially acceptably sterile.
This is also a ma or problem in the blood re-sale business where blood may i be bought from donors of an unknown background and then sold on to other parties who have no guarantee of its sterility or purity (e.g. the absence of narcotics).
The prior art does not provide, nor does it suggest, apparatus or means by which samples may be taken and prepared for use on multiple occasions, the sterilty of the sample being guaranteed before its eventual use.
Thus the prior art does not provide a blood bag (i.e. a fluid container) whose contents can be tested on a number of occasions without potentially effecting contamination. The present invention overcomes the prior art disadvantages.
According to the present invention there is provided a sealable fluid container having multiple use diagnostic test means, comprising a first volume for containing a fluid and communicating with the diagnostic test means, the first volume having an inlet and/or outlet and the first volume being capable of communicating with the test means whilst all inlets and outlets are sealed. The testing means may comprise other than culture medium.
The provision of the testing means for performing a number of tests means that the contents of the container can be tested on a number of occasions for the presence or absence of a particular substance or substances, or of a particular micro-organism such as a bacterium or virus. This is particularly advantageous in the case of blood bags since the sterility of their contents must be assured.
Sealing is achieved by closing all inlets and outlets. The arrangement of the first volume and the test means is such that in order to test a sample of the fluid, the inlet and/or outlet need not to be opened, it therefore not being possible for the testing of a sample to result in contamination of the fluid, i.e. the container remains a sealed unit whilst testing occurs. The container may be any appropriate type of fluid container, but may typically be in the form of a flexible bag such as conventional blood bags.
The container may be used to contain any fluid which may require testing whilst the container is sealed. In particular this includes biological materials such as whole blood, plasma, serum, transfusable blood products such as separated blood factors (e.g. Factor VIII, immunoglobulins, platelets etc.) or synovial fluids. Other fluids such as urine samples from athletes may be stored and tested in the container.
The first volume may communicate with the test means via a one-way valve. Thus during testing reagents may be introduced to the fluid and the reagents prevented from entering the first volume. There may, for example, be a plurality of test means, each having a one-way valve prior to the testing area. As fluid is passed to the testing means for the first time it will enter the first test means and fill it, the fluid being subsequently unable to leave the test means. A single conduit may serve to connect each of the test means to the first volume, supply of fluid along the conduit to each test means being separated by impermeable membranes, each membrane being capable of being ruptured and allowing flow when sufficient pressure is applied, although of course the conduit itself should be capable of withstanding any such pressures.
After the first test means has been used, additional fluid pressure in the conduit may cause the rupturing of a membrane preventing fluid flow to the second testing means. With the membrane ruptured, the second testing means may be used.
A wide range of testing means may be used in the present invention. For example, the testing apparatus of any of WO 96/04068, WO 96/17675, WO 96/17673 or WO/ 96/04067 may be used. Such devices operate by a "flowthrough" technique whereby the fluid to be tested is passed over a filter or membrane, the filter or membrane being at a tangent to the direction of flow. The filter or membrane may be provided with desired physical characteristics or other chemical entities (such as enzymes) to filter and/or detect specific molecules in the fluid, the resulting filtrate or reaction products being subsequently detected. This allows a small detection (i.e. testing) area to test a large volume of fluid. To accommodate such large volumes of fluid, the testing means may include a storage volume into which the tested fluid flows. Alternatively it may additionally communicate with the first volume e.g. have an outlet conduit which returns tested fluid to the first volume. Alternatively, dip-stick type testing means (WO 88/08534) may be used. The provision of a "control" marker (WO 88/08534) may be particularly useful in showing that the test has been successfully completed (irrespective of the result obtained) and for later reference in showing that a particular testing means has previously been used.
The actual reagents used in such testing means will readily apparent to one skilled in the art, for example antibodies (Harlow, E. and Lane, D., "Antibodies - A Laboratory Manual", Cold Spring Harbor Laboratory, Cold Spring Harbor Press, New York 1988) specific against a bacterial or viral antigen or an antigen displayed by another pathogen, or against a prion or toxin or narcotic such as an opiate. Other chemical entities which may be used in tests are widely known.
Me invention will be ftirther apparent from the following description, with reference to the several figures of the accompanying drawings, which show, by way of example only, forms of blood bag. Of the figures:
Figure I shows a sealable blood bag having multiple testing means.
Figure 2 shows a sealable blood bag having a single multiple use test means.
Container I comprises flexible plastic container 10 holding blood 20. Plastic container 10 has inlet/outlet 11 and sealing valve 12 to allow the entry and exit of blood 20 as required. Plastic container 10 is attached to tube 30 acting as a conduit between it and testing means 51- 55. To cause the flow of blood 20 from plastic container 11 to testing means 51-55, detachable peristaltic pump 40 is clipped onto tube 30 and used. This causes the flow of blood 20 along tube 30 towards membrane 71 and one-way valve 6 1. The pressure required for blood 20 to flow through one-way valve 61 is less then that required to rupture membrane 71. Blood flows into test means 51 and encounters filter 80 which prevents the passage of large particles such as platelets. The filtrate then passes along capillary surface 87 upon which is mounted discrete bands of bacterial detecting reagents 81, 82, viral detecting reagents 83, 84, and opiate detecting reagents 85. If the bacteria, viruses or opiates to which the reagents are specific are detected, a colour change in the appropriate band is visible. The filtrate subsequently passes to control band 86, causing a colour change indicating that the test has been successfully completed. Due to the one-way valve 61 controlling the flow of blood, it is not possible for tested blood 20, filtrate or reagents 81-86 to return to plastic container 10. This prevents any contamination of blood 20 in container 10 by reagents 81-86. Control band 86 provides a permanent record showing that testing means 51 has been used.
In a subsequent test of blood 20 in plastic container 10, peristaltic pump 40 is again attached to tube 30 and blood 20 forced through the tube towards membrane 71 and one-way valve 61. This time because of the volume of blood 20 held in testing means 51 the pressure required for blood 20 to pass through one-way valve 61 is greater than that required to rupture membrane 7 1. As pressure is applied by peristaltic pump 40, membrane 71 ruptures and blood 20 flows towards membrane 72 and one-way valve 62. The pressure required for blood 20 to flow through one-way valve 62 is less than that required to rupture membrane 72. Blood 20 flows through one-way valve 62 into testing means 52 and is tested for bacteria, viruses and opiates.
Container 10 is also provided with temperature sensing strip 90 - rather than allow blood bags to warm to room temperature or body temperature using simple convection heating, other techniques such as microwave heating are nowadays employed. However, this can lead to the excessive heating of fluids if not carefully preformed and monitored. Temperature sensing strip 90 changes colour if blood 20 is heated to temperature of more than 40'C, at which temperatures protein damage and degradation may occur and pose danger to a patient if infused.
During any testing performed, inlet/outlet valve 12 is not opened and therefore there is no possibility of contamination of blood 20.
In an alternative embodiment, container 100 comprises plastic container I 10 having inlet/outlet 111 and valve 112 and containing blood 20. Tubes 121, 122 connect plastic container I 10 with testing means 130, detachable peristaltic pump 40 being used to pump blood from plastic container 110 through tube 12 1 into testing means 13 0 and back into plastic container I 10 via tube 122.
Testing means 130 comprises hollow fibre membrane 140 arranged in a "cross-flow" fashion i.e. tangential to the direction of flow of blood 20. Membrane 140 is enclosed by clear plastic outer tube 150 on whose inner surface is deposited discrete bands of reagents 81-85. As blood 20 is pumped through hollow fibre membrane 140 filtrate (not including e.g. platelets) passes through membrane 140 into the volume 160 defined between tube 150 and membrane 140. The filtrate interacts with reagents 81-85 which change colour if the molecule against which they are specific is detected. Blood 20 and filtrate are forced back through membrane 140 by the flow of new filtrate into volume 150, and then flows through tube 122 back into plastic container I 10.
The above steps with container 100 can be repeated whenever it is necessary to test blood 20.
It will be appreciated that it is not intended to limit the invention to the above example only, many variations, such as might readily occur to one skilled in the art, being possible, without departing from the scope thereof as defined by the appended claims.
Claims (6)
- A sealable fluid container having multiple use diagnostic test means, comprising a first volume for containing a fluid, and communicating with the diagnostic test means, the first volume having an inlet and/or outlet and the first volume being capable of communicating with the test means whilst all inlets and outlets are sealed.
- 2. A sealable fluid container according to claim 1, being a flexible bag.
- 3. A sealable fluid container according to either of the preceding claims, the fluid being whole blood, plasma, serum, a transfusable blood product or synovial fluids.
- 4. A sealable fluid container according to claim 3, the fluid being a transfusable blood product selected from the group of Factor VM, immunoglobulins and platelets.
- 5. A sealable fluid container according to any one of the preceding claims, the first volume communicating with the test means via a one-way valve.
- 6. A sealable fluid container according to any one of the preceding claims, the testing means having a fluid inlet and fluid outlet communicating with the first volume, tested fluid being returned to the first volume.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9815941A GB2339903A (en) | 1998-07-23 | 1998-07-23 | Fluid container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9815941A GB2339903A (en) | 1998-07-23 | 1998-07-23 | Fluid container |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9815941D0 GB9815941D0 (en) | 1998-09-23 |
GB2339903A true GB2339903A (en) | 2000-02-09 |
Family
ID=10835955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9815941A Withdrawn GB2339903A (en) | 1998-07-23 | 1998-07-23 | Fluid container |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2339903A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004055198A2 (en) | 2002-12-12 | 2004-07-01 | Chiron Corporation | Device and method for in-line blood testing using biochips |
FR2868946A1 (en) * | 2004-04-15 | 2005-10-21 | Maco Pharma Sa | Pouch, e.g. for perfusion fluid, comprises loop connected to two orifices to allow sampling |
FR2943532A1 (en) * | 2009-03-30 | 2010-10-01 | Maco Pharma Sa | POCKET SYSTEMS COMPRISING A SAMPLING CONTAINER HAVING AN OPENING DEVICE |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107723230B (en) * | 2017-10-26 | 2023-09-29 | 山东省医疗器械产品质量检验中心 | Plastic blood bag detection device |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4846005A (en) * | 1986-12-12 | 1989-07-11 | Baxter International Inc. | Set with attachable sample cell |
US4945060A (en) * | 1988-03-15 | 1990-07-31 | Akzo N. V. | Device for detecting microorganisms |
WO1992019764A1 (en) * | 1991-05-08 | 1992-11-12 | Baxter Diagnostics Inc. | Method and apparatus to detect bacterial contamination of transfusable blood |
JPH0691262A (en) * | 1992-09-14 | 1994-04-05 | Airiin:Kk | Water treatment apparatus |
WO1996004067A1 (en) * | 1994-08-02 | 1996-02-15 | Fsm Technologies Ltd. | Membrane filter unit |
WO1996037177A2 (en) * | 1995-05-22 | 1996-11-28 | The National Blood Authority | Apparatus and method for detecting a contaminant in a fluid |
-
1998
- 1998-07-23 GB GB9815941A patent/GB2339903A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4846005A (en) * | 1986-12-12 | 1989-07-11 | Baxter International Inc. | Set with attachable sample cell |
US4945060A (en) * | 1988-03-15 | 1990-07-31 | Akzo N. V. | Device for detecting microorganisms |
WO1992019764A1 (en) * | 1991-05-08 | 1992-11-12 | Baxter Diagnostics Inc. | Method and apparatus to detect bacterial contamination of transfusable blood |
JPH0691262A (en) * | 1992-09-14 | 1994-04-05 | Airiin:Kk | Water treatment apparatus |
WO1996004067A1 (en) * | 1994-08-02 | 1996-02-15 | Fsm Technologies Ltd. | Membrane filter unit |
WO1996037177A2 (en) * | 1995-05-22 | 1996-11-28 | The National Blood Authority | Apparatus and method for detecting a contaminant in a fluid |
Non-Patent Citations (1)
Title |
---|
WPI Accession No. 85-161616/198527 & JP 06 091 262 A * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004055198A2 (en) | 2002-12-12 | 2004-07-01 | Chiron Corporation | Device and method for in-line blood testing using biochips |
EP1570043A2 (en) * | 2002-12-12 | 2005-09-07 | Chiron Corporation | Device and method for in-line blood testing using biochips |
EP1570043A4 (en) * | 2002-12-12 | 2008-01-23 | Novartis Vaccines & Diagnostic | Device and method for in-line blood testing using biochips |
US7785782B2 (en) | 2002-12-12 | 2010-08-31 | Novartis Vaccines And Diagnostics, Inc. | Device and method for in-line blood testing using biochips |
FR2868946A1 (en) * | 2004-04-15 | 2005-10-21 | Maco Pharma Sa | Pouch, e.g. for perfusion fluid, comprises loop connected to two orifices to allow sampling |
FR2943532A1 (en) * | 2009-03-30 | 2010-10-01 | Maco Pharma Sa | POCKET SYSTEMS COMPRISING A SAMPLING CONTAINER HAVING AN OPENING DEVICE |
Also Published As
Publication number | Publication date |
---|---|
GB9815941D0 (en) | 1998-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10801004B2 (en) | Cassette for sterility testing | |
EP1135459B1 (en) | Method for culturing microorganisms in prefilled flexible containers | |
KR100436473B1 (en) | Microbial detection device and method | |
US4416984A (en) | Sterilization indicator | |
US20220160271A1 (en) | Device for trapping an initial flow of blood | |
DE69827019T2 (en) | DEVICE AND METHOD FOR PROCESSING BIOLOGICAL CELLS | |
JP4183508B2 (en) | Integrated filtration and detection device | |
WO1995023026A1 (en) | Apparatus and method for quantification of biological material in a liquid sample | |
JP2005524445A (en) | Apparatus and method for detecting bacteria in blood products | |
CN105828842B (en) | Sample preparation unit and sample preparation device | |
CN213787425U (en) | Transfer device and transfer device assembly for isolating a blood collection of an initial collection portion | |
KR20020097140A (en) | Biological fluid processing | |
US5667985A (en) | Tissue biopsy cell suspender for cell analysis | |
KR20210111266A (en) | Cell processing units, cell processing systems and methods of use thereof | |
HU182440B (en) | Test tube for microbiologic tests | |
GB2339903A (en) | Fluid container | |
US20050221417A1 (en) | Sterility testing apparatus | |
US4459936A (en) | Apparatus for indicating whether the interior of a container has been sterilized during a sterilization process | |
AU2012202281B2 (en) | Detection of bacteria in biological fluids | |
WO2020008067A1 (en) | Sampling device and method | |
US10495555B2 (en) | Filter-cartridge based fluid-sample preparation and assay system | |
WO1990013624A1 (en) | Microorganism growth culture system, method and filtration unit utilized therewith | |
JP3519793B2 (en) | Microorganism testing equipment | |
JPH09275972A (en) | Culture of bacterium, examination of bacterium and bacterium incubator used therefor | |
AU728129B2 (en) | Apparatus and method for quantification of biological material in a liquid sample |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |